Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DermaGold Indicated for Use of Shockwave Treat of Diabetic Foot Ulcers in Patients With Diabetes Mellitus

NCT00366132 is registered in ClinicalTrials.gov with Tissue Regeneration Technologies as lead sponsor.

NCT NCT00366132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00366132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DermaGold Indicated for Use of Shockwave Treat of Diabetic Foot Ulcers in Patients With Diabetes Mellitus
Lead sponsor
Tissue Regeneration Technologies
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2006
Completion date
Not reported
Enrollment
200
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic diabetic foot ulcers